There are many decisions that men need to make with respect to prostate health and issues such as prostatitis, benign prostatic hypertrophy (BPH) and prostate cancer. New data from randomized trials performed in this country and in Europe are leading to changes in the way we care for men concerned about their risk of prostate cancer and guidelines now recommend that men begin screening as early as age 40.
Learn more about the new recommendations and other important facts about prostate health, in this online chat with Dr. Kevin Slawin.
Kevin Slawin, M.D., currently serves as director of urology at Memorial Hermann-Texas Medical Center. He is also director for the Vanguard Urologic Institute and the Texas Prostate Center. A recognized authority on prostate disease, Dr. Slawin has dedicated his life to the improvement of care for patients with prostate disease.